A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Orphenadrine D3 | CAS 1185011-75-9 - Request Quote

Picture of Orphenadrine D3

Orphenadrine D3

SZ CAT No:SZ-O015D01
CAS No
1185011-75-9
Mol.F.
C18H20D3NO
Mol.Wt.
272.4
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Orphenadrine D3 is chemically N-Methyl-N-(methyl-d3)-2-(phenyl(o-tolyl)methoxy)ethan-1-amine. Orphenadrine D3 is supplied with detailed characterization data compliant with regulatory guideline. Orphenadrine D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Orphenadrine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1185011-75-9

Purchase 1185011-75-9

Order 1185011-75-9

Enquire 1185011-75-9

price of 1185011-75-9

1185011-75-9 Supplier

1185011-75-9 Manufacturer

1185011-75-9 Exporter

buy high quality Orphenadrine D3

Purchase Orphenadrine D3

Orphenadrine D3 suppliers

Orphenadrine D3 manufacturers

Orphenadrine D3 price

Order Orphenadrine D3

Enquire Orphenadrine D3

Orphenadrine D3 cost

Orphenadrine D3 Supplier

Orphenadrine D3 Distributor

Orphenadrine D3 for Method Validation

Orphenadrine Reference Standard

Orphenadrine D3 for ANDA Filing

Orphenadrine D3 for Forced Degradation Studies

Orphenadrine D3 Identification Standards

Orphenadrine D3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,